Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer
Clinical trial NCT00683358 · UNKNOWN
Trial details
- NCT number
- NCT00683358
- Sponsor
- Tokyo University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2009-04-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.